Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer. - Wikidata - wikimedia - TriplyDB

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

http://www.wikidata.org/entity/Q42183073

about

Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment The impact of the myeloid response to radiation therapy A method for identification and analysis of non-overlapping myeloid immunophenotypes in humans Coordinated regulation of myeloid cells by tumours Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma.Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling.Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer.A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.Effect of TLR agonists on the differentiation and function of human monocytic myeloid-derived suppressor cells Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease.The consequence of immune suppressive cells in the use of therapeutic cancer vaccines and their importance in immune monitoring A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.Blood classical monocytes phenotype is not altered in primary non-small cell lung cancer.Dendritic cell-based vaccines: barriers and opportunities A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma Stromal-dependent tumor promotion by MIF family members.Clinical recovery from surgery correlates with single-cell immune signatures.Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.Analysis of monocytic and granulocytic myeloid-derived suppressor cells subsets in patients with hepatitis C virus infection and their clinical significance Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells.Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation.The immune microenvironment of myeloma Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients Myeloid-derived suppressor cells participate in preventing graft rejection.Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphoma TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients.Increased CTLA-4(+) T cells and an increased ratio of monocytes with loss of class II (CD14(+) HLA-DR(lo/neg)) found in aggressive pediatric sarcoma patients Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response.SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer.Association of an increased frequency of CD14+ HLA-DR lo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL).Identification of a novel HLA-G+ regulatory population in blood: expansion after allogeneic transplantation and de novo HLA-G expression at graft-versus-host disease sites Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells.Myeloid derived suppressor cells in human diseases Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.Breaking bad habits: Targeting MDSCs to alleviate immunosuppression in prostate cancer.

P2860

Q26777205-DC6034C7-56A1-4317-9AB9-54508FAA0F7B Q26799126-17594134-8CCD-4B4B-8606-92F75F4A8E17 Q26851643-812BBC23-7B93-4C24-811E-354AAF514682 Q27310807-1D4FCEF7-F4BC-4387-A00C-56AE3F420794 Q28395157-BC97C701-BC49-4123-841C-D019D48BAF20 Q33759661-2FE905F7-A4B7-41BB-9650-4630A343EC00 Q33772651-50D490A0-073E-4846-AA2E-72C88A7FCF57 Q34290252-E7E3051B-8230-4E84-8451-CCECE4C7193A Q34403480-6EEFA7FD-F9CE-44FE-B57D-217EAA388707 Q34469457-FC7C1548-2642-402D-9050-109C4BAFDB03 Q34517267-A7679FD4-7ECD-4524-9AE3-C46C23602E9B Q34557531-9DEDD601-AEBF-47F2-BA45-0CCEF0FECDD6 Q34570094-509BD05B-E2AC-4E72-810E-764033ABDC20 Q34600087-E9CDD5CC-DD54-4905-9F82-DB083B6A200C Q34657618-B1875E3A-164C-4DAD-8D3D-368787E3EA05 Q34661797-F4AC80FF-A3F0-4DB5-A446-7CFA6CE685C0 Q34699543-2D79F646-A1A5-49D6-8C66-AA0B958F106A Q34944820-FC3304D1-E853-4AD2-8E27-F42D9F3E62C5 Q35100326-3A4E4736-296A-41FE-B173-C504FAF74F73 Q35100546-45D044D2-006B-4817-A7B6-BCDAE10123F1 Q35178139-2DC0B394-9639-41AD-B6E8-A8A3CFDF447D Q35553327-F7698FEF-42A0-4E01-8D0C-406FB63F0E52 Q35579455-1794D4D8-9CF2-4923-889A-0D09B03C9C18 Q35603152-B587D29E-D24E-4599-8DFA-31D9718B655B Q35629271-4CE46710-A425-4597-B7F5-7C7767EB6114 Q35852813-A05EFD50-BF8B-491B-8A6C-FB42821D0722 Q35912988-BB236634-FAAF-41F6-ADC1-81920984C24E Q35921894-F18B104D-685B-4EA0-82DD-EDFB8E89CAEF Q35958114-93C37016-A626-4BC1-A69F-86862712D7B0 Q35965142-19958EFB-A127-4135-B73F-C4B3C03740E7 Q36018144-13F2A3FB-BF65-454F-9BE0-D170411C68BE Q36061481-589AC6E8-99A6-414B-9898-C7494D93CC1B Q36118086-1FCE7B67-796A-4162-ABF5-8E870ECF2B6E Q36206949-894667CC-68C6-4270-B8B8-623B310B2626 Q36216198-F39C1DD2-2A8E-40D1-ADA4-79B830BBF97E Q36249153-655FBE0F-1F21-4A57-B784-D0E8C8821DE8 Q36338349-7555BB0B-AE76-4218-904B-97EE64E1593B Q36447669-62B2BCC5-8BB5-4044-BC7A-20F3D4D98EE4 Q36489379-141E1508-2F26-4E99-BBC9-24DF7BEB6F7B Q36710940-FB09D6BA-790E-4450-8169-6AA6B1BB8405

P2860

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

http://www.wikidata.org/entity/Q42183073

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

@en

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

@nl

type

label

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

@en

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

@nl

prefLabel

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

@en

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

@nl

P1433

Q42183073-67175A9E-4709-4D43-9D98-4E3CC59A34C2

P1476

Q42183073-BB47ADC1-69F1-415F-8C45-FEB5FDDD2BBD

P2093

Q42183073-608731FF-A8C1-4266-91AF-E8D2F4B2C305

Q42183073-622D751E-6CF5-4E73-8A52-3A11A4637E35

Q42183073-731EDBB6-A9D0-4794-B44C-5CA90CE33D08

Q42183073-D4C1890A-FF05-4FED-946D-9E5C158ED085

Q42183073-DBEC2323-7944-4192-AFFE-2C69510D8B3E

Q42183073-EDD09E87-E57C-4A42-98BA-4AFDD1FDD302

P2860

Q42183073-01D7640E-96CA-4D99-8F84-5025DC20707F

Q42183073-069687DA-5811-4645-93CB-33E2D0B50EF3

Q42183073-0EF6B3B0-A9F5-4ED1-B781-3BE9ACA8DF15

Q42183073-2041009C-EE7D-4DC8-ACD0-A2517842D88B

Q42183073-23BCD12A-6CEC-4A12-864B-B78FF6759A7E

Q42183073-261C8A03-E574-494B-82AA-A7E6F80959A3

Q42183073-3C14FFD8-5052-446B-9B99-A5AA8FAC6EB7

Q42183073-3E51390D-6037-4F58-8CD5-E28DD9DD0EE1

Q42183073-412DDB4F-9C78-4243-B757-328CED1741EA

Q42183073-426ACC7C-B498-442A-A3D1-9912BECB343E

P304

Q42183073-0DB5ADF2-3875-486B-AF66-83FC6D914E9E

P31

Q42183073-C7A02E21-7E95-463C-9A88-0D77555D9EF2

P356

Q42183073-56371C97-87D0-4738-8C85-4A54E9339ED5

P433

Q42183073-2F040DEF-3AF0-4982-97D3-884D6E421C8A

P478

Q42183073-FD04C315-C589-4DE7-8EA2-775FFFF85E95

P50

Q42183073-E175E487-97EF-4894-96A3-898F395D8F84

P577

Q42183073-D5BD0285-0D31-4BC7-B04B-5A80BBE115B6

P5875

Q42183073-B27D687F-6461-4880-A99F-3ED5E65D16F4

P698

Q42183073-98906D1F-5CCB-44FC-8004-D72B0559616B

P932

Q42183073-4C57F913-3A66-470C-8F25-AF180401EDE8

P356

P1433

P1476

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

@en

P2093

Carol L Szumlanski

http://www.w3.org/2001/XMLSchema#string

Peggy A Bulur

http://www.w3.org/2001/XMLSchema#string

Rui Qin

http://www.w3.org/2001/XMLSchema#string

Stanimir Vuk-Pavlović

http://www.w3.org/2001/XMLSchema#string

Xinghua Zhao

http://www.w3.org/2001/XMLSchema#string

Yi Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Myeloid-derived suppressor cells: linking inflammation and cancer

Dendritic cells and the control of immunity

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen.

Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers

CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.

CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages.

Immature myeloid cells and cancer-associated immune suppression.

Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells

P304

443-455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.21078

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38079223

http://www.w3.org/2001/XMLSchema#string

P698

19902470

http://www.w3.org/2001/XMLSchema#string

P932

2935631

http://www.w3.org/2001/XMLSchema#string